Chronos Archive seal

Review checklist: Susan B. Anthony (HR-NI014)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check HFpEF therapy choices and potassium monitoring in an 85-year-old.
provenance reviewnot_startedNPS page, the 1898 Harper biography (Project Gutenberg), and two museum pages logged; reports of valvular heart disease were not verified and are not used.
safe messaging reviewnot_startedNo behavioral-health content; death recorded without graphic detail.

Judgment calls (dossier editorial resolutions)

  1. Index age. Anthony died at 86, so an episode at that age would have to fit between her birthday on February 15 and her death on March 13. The modern episode presents her at 85, one year before her final illness, so that a chronic heart failure course can unfold. The index visit is March 16, 2026 (true frame March 16, 1905) and the last chronic-care visit is September 28, 2026 (true frame September 28, 1905); the sick and wellness visits are described below. Her final illness and death fall after the index date and remain only in the historical timeline.
  2. Modern diagnosis. The NPS records heart failure and pneumonia as the causes of death (D). The type of heart failure is not documented. The synthetic episode makes it heart failure with preserved ejection fraction, the most common form in women of her age, and adds synthetic hypertension; no blood pressure from her lifetime appears in the cited sources.
  3. Earlier illnesses. The 1891 la grippe and the 1895 faint with a month of “nervous prostration” are recorded in past medical history with their contemporary labels. Neither is reinterpreted as heart disease.
  4. Family history. The 1898 biography gives the ages at death of her parents and grandparents but no causes except her father's “acute neuralgia of the stomach,” which is reported as written.
  5. Not used. Reports that she had long-standing valvular heart disease, and a press account attributing her death to “heart failure induced by pneumonia of both lungs,” appeared in search summaries and secondary pages but could not be confirmed in a fetched primary or reliable source, so they are not recorded. Volume 3 of the Harper biography, which covers her last years, was not reviewed. The exact place of her “Failure is impossible” remarks in February 1906 is reported inconsistently and is not used.
  6. Sick and wellness visits. Two visits were added after the chronic-care schedule: an unscheduled sick visit on August 17, 2026 (true frame August 17, 1905) for a viral bronchitis, and a subsequent annual wellness visit on October 19, 2026 (true frame October 19, 1905). Both are synthetic. The bronchitis does not echo a documented illness. It was chosen because respiratory infection is a recognized trigger for heart failure decompensation, and her documented 1891 la grippe and fatal 1906 pneumonia make respiratory illness a reasonable teaching thread. The wellness visit adds a synthetic hearing concern, and its advance care planning names no real person as her health care agent.
  7. Focused visits. The three chronic-care follow-ups (two weeks, three months, and six months) are documented as focused visits on the CMID heart failure monograph. Each lists every item the protocol calls for at that point, with its interval and status. The examination findings at intake that the two-week note compares against (jugular venous pressure 10 cm, 2+ ankle edema, basal crackles) are synthetic. The schedule has no visit one to two weeks after spironolactone was started, so the three-month note records that missed potassium check as a protocol deviation instead of inventing a result.
  8. Anthony died in 1906, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-06-29
Progress note 03 (C-CDA)
Basic metabolic panel 1 to 2 weeks after starting spironolactoneOnce, after starting a mineralocorticoid antagonistNot drawn in the two-week window, a deviation from the protocol. Today's potassium and kidney function are normal, so no harm resulted; the reminder is now in her chart

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-10-19
Progress note 06 (C-CDA)
PreventionBone density (DXA)OrderedNo prior scan on record; recommended for women 65 and older, and her low body weight raises fracture risk
2026-10-19
Progress note 06 (C-CDA)
PreventionHearingReferredAudiology referral for a failed right whispered-voice test

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

None.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-03-16NT-proBNP1650 pg/mL (high)High
2026-03-30eGFR58 mL/min/1.73 m² (low)Low
2026-03-30Left atrial volume index42 mL/m² (high)High
2026-03-30Mitral E/e' ratio (average)16 (high)High
2026-06-29NT-proBNP720 pg/mL (high)High